Publications

Malaria at Parturition in Nigeria: Current Status and Delivery Outcome

Mokuolu O. A., Falade C. O., Orogade A. A., Okafor H. U., Adedoyin O. T., Oguonu T. A., Dada-Adegbola H. O., Oguntayo O. A., Ernest S. K., Hamer D. H., Callahan M. V.

Infect Dis Obstet Gynecol. 2009 Jul; 2009:473971.

Clinical and laboratory features of congenital malaria in Nigeria

Orogade AA, Okafor HU, Falade CO, Mokuolu OA, Mamman AI, Ogbunu TA, Ogunkunle OO, Ernest SK, Callahan MV, Hamer DH

Journal of Pediatric Infectious Diseases 3. 2008 Jan; 181-187.

Epidemiology of Congenital Malaria in Nigeria: A Multi-Centre Study

Falade C., Mokuolu O., Okafor H., Orogade A., Falade A., Adedoyin O., Oguonu T., Aisha M., Hamer D. H., Callahan M. V.

Trop Med Int Health. 2007 Oct; 12(11):1279-87.

Intermittent Preventive Treatment with Sulphadoxine-Pyrimethamine is Effective in Preventing Maternal and Placental Malaria in Ibadan, South-Western Nigeria

Falade C. O., Yusuf B. O., Fadero F. F., Mokuolu O. A., Hamer D. H., Salako L. A.

Malar J. 2007 Jul; 6:88.

Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria

Catherine O Falade, Bidemi O Yusuf, Francis F Fadero, Olugbenga A Mokuolu, Davidson H Hamer and Lateef A Salako

Malaria Journal. 2007 May; 6(88).

Why do firms take action on HIV/AIDS? Evidence from Nigeria

Rosen S., Vincent J. R., MacLeod W., Thea D. M., Simon J.

Journal of Business in Developing Countries. 2004 Jan; 8(1):1-38.

Who’s at Risk? Men’s STD Experience and Condom Use in Southwest Nigeria

Messersmith L. J., Kane T. T., Odebiyi A. I., Adewuyi A. A.

Stud Fam Plann. 2000 Oct; 31(3):203-16.